Biocon : Website stats and valuation - Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company. Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential oral insulin. Novel Biologics, Biosimilars, Fermentation based APIs, statins, Tacrolimus, Sirolimus, Everolimus, Human Insulin, Glargine, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Generic formulations, Trastuzumab, Itolizumab, Nimotuzamab, BioMab EGFR, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Lispro, Peptides, Insulin Aspart, diabetes, cancer, oncology, autoimmune, breast cancer, head neck cancer, psoriasis, chronic disease

Country:, North America, US

City: -87.6272 Illinois, United States

  • Layton Knight - Warning: designed and built for only "casual" use

    While the product itself produces an amazing ice-cream like dessert, it's designed only to produce one or two servings per use. Last night I attempted to produce six servings for a dinner party. I was quite shocked. After 15 minutes, the machine started to produce odors of "burning plastic." I was only able to produce enough for four servings before I noticed that the machine started to over heat. I still enjoy using the machine and I love the fruity ice cream it makes, but I am constantly reminded that I can only use it for about fifteen to twenty minutes at a time.

  • Lori - Great test taking tips

    I really appreciate this book so far, since it is full of detailed steps on how to approach NCLEX style questions. There are some practice questions (I got Davis's Q&A for more questions) and I will use all of them, and I like how they show how they arrived at the correct answer.